CLSN Share Price |
||||
| Open | 2.46 | Change | Price | % |
| High | 2.58 | 1 Day | -0.24 | -9.13 |
| Low | 2.35 | 1 Week | -0.81 | -25.31 |
| Close | 2.39 | 1 Month | 2.14 | 856.00 |
| Volume | 588359 | 1 Year | 1.12 | 88.19 |
| 52 Week High 4.96 | ||||
| 52 Week Low 0.19 | ||||
| CLSN Important Levels | |
| Resistance 2 | 2.60 |
| Resistance 1 | 2.52 |
| Pivot | 2.44 |
| Support 1 | 2.26 |
| Support 2 | 2.18 |
| NASDAQ USA Most Active Stocks | |||
| YHOO | 52.58 | 0.00% | |
| YHOO | 52.58 | 0.00% | |
| YHOO | 52.58 | 0.00% | |
| DCTH | 0.16 | -33.33% | |
| FTR | 1.22 | 8.93% | |
| FTR | 1.22 | 8.93% | |
| ASTI | 0.00 | 0.00% | |
| FNFG | 10.18 | -0.20% | |
| DELL | 13.86 | 0.22% | |
| RFMD | 16.59 | -2.07% | |
| NASDAQ USA Top Gainers Stocks | |||
| OPXAW | 0.12 | 200.00% | |
| AVEO | 1.25 | 71.23% | |
| LOCM | 0.09 | 50.00% | |
| MYRX | 0.09 | 50.00% | |
| SNCR | 16.24 | 33.33% | |
| QUIK | 1.60 | 31.15% | |
| WRES | 0.09 | 28.57% | |
| IIN | 8.35 | 27.48% | |
| IIN | 8.35 | 27.48% | |
| IIN | 8.35 | 27.48% | |
| NASDAQ USA Top Losers Stocks | |||
| TXCC | 0.01 | -95.00% | |
| HCIIP | 10.10 | -67.52% | |
| TOPS | 0.80 | -66.67% | |
| CRMB | 0.27 | -57.81% | |
| KIOR | 0.03 | -57.14% | |
| SPIR | 0.01 | -50.00% | |
| OSH | 0.26 | -49.02% | |
| OSH | 0.26 | -49.02% | |
| DVOX | 0.05 | -44.44% | |
| PRXI | 0.21 | -43.24% | |
Celsion Corporation (NASDAQ: CLSN)
| CLSN Technical Analysis | 3 |
| As on 23rd Jun 2017 CLSN Share Price closed @ 2.39 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.84 & Buy for SHORT-TERM with Stoploss of 1.11 we also expect STOCK to react on Following IMPORTANT LEVELS. | |
| CLSN Target for June | |
| 1st Target up-side | 4.5 |
| 2nd Target up-side | 5.73 |
| 3rd Target up-side | 6.97 |
| 1st Target down-side | 0.96 |
| 2nd Target down-side | -0.27 |
| 3rd Target down-side | -1.51 |
Celsion Corporation ( NASDAQ USA Symbol : CLSN ) Sector : Healthcare And Other Stocks in Same Sector |
|||||
|
ABAX
52.54 0.81 (1.57 %) LT : Buy ST : Strong Buy |
ABIO
2.35 -0.10 (-4.08 %) LT : Sell ST : Sell |
ABMD
144.49 -0.24 (-0.17 %) LT : Strong Buy ST : Strong Buy |
ACAD
29.24 0.56 (1.95 %) LT : Sell ST : Sell |
ACHC
48.03 0.47 (0.99 %) LT : Buy ST : Strong Buy |
|
|
|
||||||||||||||||||||||
|
Interactive Technical Analysis Chart Celsion Corporation ( CLSN NASDAQ USA )
Your Comments and Response on Celsion Corporation
CLSN Business Profile
Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer. As of December 31, 2011, the Company's product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical trial for colorectal liver metastasis (CRLM) and a Phase II clinical trial for recurrent chest wall breast cancer. ThermoDox is a liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a range of cancers. Localized heat at mild hyperthermia temperatures releases the encapsulated doxorubicin from the liposome enabling high concentrations of doxorubicin to be deposited preferentially in and around the targeted tumor. Liposomes are manufactured submicroscopic vesicles consisting of a discrete aqueous central compartment surrounded by a membrane bilayer consisted of naturally occurring lipids.